Literature DB >> 18025428

The effect of publication on Internet-based solicitation of personal-injury litigants.

David N Juurlink, Laura Y Park-Wyllie, Moira K Kapral.   

Abstract

Serious adverse drug events can prompt personal-injury lawsuits. However, the extent to which biomedical publication regarding drug-induced harm can influence the legal process has not been well characterized. Using an advanced Google search strategy, we determined the number of Internet "hits" for websites soliciting plaintiffs for medicolegal action before and after publication of a study that highlighted the risk of dysglycemia among patients taking the antibiotic gatifloxacin. We found that early online release and print publication were associated with an immediate and sustained increase in the number of websites soliciting plaintiffs for legal action.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18025428      PMCID: PMC2072992          DOI: 10.1503/cmaj.070652

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  2 in total

1.  Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.

Authors:  David N Juurlink; Muhammad M Mamdani; Douglas S Lee; Alexander Kopp; Peter C Austin; Andreas Laupacis; Donald A Redelmeier
Journal:  N Engl J Med       Date:  2004-08-05       Impact factor: 91.245

2.  Outpatient gatifloxacin therapy and dysglycemia in older adults.

Authors:  Laura Y Park-Wyllie; David N Juurlink; Alexander Kopp; Baiju R Shah; Therese A Stukel; Carmine Stumpo; Linda Dresser; Donald E Low; Muhammad M Mamdani
Journal:  N Engl J Med       Date:  2006-03-01       Impact factor: 91.245

  2 in total
  3 in total

1.  Association of Attorney Advertising and FDA Action with Prescription Claims: A Time Series Segmented Regression Analysis.

Authors:  Elizabeth C Tippett; Brian K Chen
Journal:  Drug Saf       Date:  2015-12       Impact factor: 5.606

2.  Information about a discontinued drug.

Authors:  Joel Lexchin
Journal:  CMAJ       Date:  2008-03-11       Impact factor: 8.262

3.  Moxifloxacin safety: an analysis of 14 years of clinical data.

Authors:  Paul M Tulkens; Pierre Arvis; Frank Kruesmann
Journal:  Drugs R D       Date:  2012-06-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.